Maintaining the trust of physicians and the public in the medical literature: Report of a Task Force on Scientific Publishing of Clinical Trials

Journal of Bone and Mineral Research

Volumn 22, Issue 11, 2007, Pages 1661-1667

  Shane, Elizabeth ^a   Civitelli, Roberto ^b   Delmas, Pierre D ^b   Drezner, Marc ^b   Eisman, John A ^b   Lindsay, Robert ^b   Lorenzo, Joseph ^b   Miller, Paul ^b   Ralston, Stuart ^b   Reid, Ian ^b   Siris, Ethel ^b  

^a Department of Medicine ^*  (United States)

^b NONE

Author keywords

American Association of Medical Colleges Guidelines; Clinical trials; Conflict of interest; Industry; RAND methodology

Indexed keywords

ARTICLE; BONE DISEASE; CLINICAL TRIAL; CONFLICT OF INTEREST; EDITOR; EMPLOYEE; FUNDING; HUMAN; INFORMATION SERVICE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; MINERAL METABOLISM; PHYSICIAN; PRACTICE GUIDELINE; PUBLICATION; QUALITY CONTROL; STATISTICAL ANALYSIS; TRUST; ADVISORY COMMITTEE; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; INDUSTRY; PUBLISHING; STANDARD;

ADVISORY COMMITTEES; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; EDITORIAL POLICIES; FINANCIAL SUPPORT; GUIDELINES AS TOPIC; HUMANS; INDUSTRY; PERIODICALS AS TOPIC; PHYSICIANS; PUBLISHING; TRUST;

EID: 38449088351     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.07090c     Document Type: Article

References (19)

1. AUTM Licensing Survey F 2000 A Survey Summary of Technology Licensing (and Related) Performance for U.S. and Canadian Academic and Nonprofit Institutions, and Patent Management Forms. Association of University Technology Managers, Northbrook, IL, USA.
2. Bodenheimer T 2000 Uneasy alliance. Clinical investigators and the pharmaceutical industry. N Engl J Med 342:1539-1544.
3. Moses H, Martin J 2001 Academic relationships with industry: A new model for biomedical research. JAMA 285:933-935.
4. Angell M 2000 Is academic medicine for sale? N Engl J Med 342:1516-1518.
5. Smith R 2005 Medical journals are an extension of the marketing arm of pharmaceutical companies. PLosMed 2:e138.
6. Bekelman J, Li Y, Gross C 2003 Scope and impact of financial conflicts of interest in biomedical research. JAMA 289:454-464.
7. Bhandari M, Busse J, Jackowski D, Montori V, Schunemann H, Sprague S, Mears D, Schemitsch E, Heels-Andsell D, Devereaux P 2004 Association between industry funding and statistically significant pro-indistry findings in medical and surgical randomized trials. Can Med Assoc J 17:481-483.
8. Buchkowsky S, Jewesson P 2004 Industry sponsorship and authorship of clinical trials over 20 years. Ann Pharmacother 38:579-585.
9. Perlis R, Perlis C, Wu Y, Hwang C, Joseph M, Nierenberg A 2005 Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 162:1957-1960.
10. Spilker B The drug development and approval process. Available at http://www.phrma.org.
11. Gibson L 2004 GlaxoSmithKline to publish clinical trials after US lawsuit. BMJ 328:1513.
12. Hrachovec J, Wright J 2001 Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA 286:2398.
13. Maisel W 2005 Safety issues involving medical devices: Implications of recnet implantable cardioverter-defibrillator malfunctions. JAMA 294:955-958.
14. Editors ICoMJ Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Available at http://www.ICMJE.org.
15. DeAngelis C, Fontanarosa P, Flanagin A 2001 Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 286:89-91.
16. AAMC 2006 AAMC Principles for Protecting Integrity in the Conduct and Reporting of Clinical Trials. Available at http://www.aamc.org/research/ clincialtrialsreporting/start.htm.
17. Brook R 1994 The RAND/UCLA appropriateness method. In: McCormick K, Moore S, Siegel R (eds.) Clinical Practice Guideline Development. Methodology Perspectives. US Department of Health and Human Services, Rockville, MD, USA, pp. 59-70.
18. Altman D, Schulz K, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche P, Lang T, Trials) CGCSoR 2001 The revised CONSORT Statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134:663-94.
19. Ioannidis J, Evans S, Gotzsche P, O'Neill R, Altman D, Schulz K, Moher D 2004 Better reporting of harms in randomized trials: An extension of the CONSORT statement. Ann Intern Med 141:781-788.